Shanghai OPM (China) Today
| 688293 Stock | 44.36 0.41 0.92% |
Performance15 of 100
| Odds Of DistressLess than 1
|
Shanghai OPM is trading at 44.36 as of the 22nd of November 2024, a 0.92% down since the beginning of the trading day. The stock's open price was 44.77. Shanghai OPM has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Shanghai OPM Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shanghai OPM is entity of China. It is traded as Stock on SHG exchange. The company has 114.77 M outstanding shares. More on Shanghai OPM Biosciences
Moving together with Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai OPM's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai OPM or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Zhihua Xiao | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Shanghai OPM's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shanghai OPM's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Shanghai OPM can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shanghai OPM's financial leverage. It provides some insight into what part of Shanghai OPM's total assets is financed by creditors.
| |||||
Shanghai OPM Biosciences (688293) is traded on Shanghai Stock Exchange in China and employs 285 people. Shanghai OPM is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai OPM's market, we take the total number of its shares issued and multiply it by Shanghai OPM's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai OPM Biosciences operates under Biotechnology sector and is part of Health Care industry. The entity has 114.77 M outstanding shares.
Shanghai OPM generates positive cash flow from operations, but has no cash available
Check Shanghai OPM Probability Of Bankruptcy
Ownership AllocationShanghai OPM Biosciences shows a total of 114.77 Million outstanding shares. Shanghai OPM Biosciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai OPM Biosciences Risk Profiles
Although Shanghai OPM's alpha and beta are two of the key measurements used to evaluate Shanghai OPM's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.6 | |||
| Semi Deviation | 3.78 | |||
| Standard Deviation | 5.12 | |||
| Variance | 26.16 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai OPM without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Shanghai OPM Corporate Executives
Elected by the shareholders, the Shanghai OPM's board of directors comprises two types of representatives: Shanghai OPM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai OPM's management team and ensure that shareholders' interests are well served. Shanghai OPM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai OPM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Liangping Ni | Secretary CFO | Profile |
Other Information on Investing in Shanghai Stock
Shanghai OPM financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai OPM security.